Mycobacterium kansasii
64 results
1 - 64
Mycobacterium kansasii- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- Pulmonary disease, HIV-negative, or HIV-positive without HAART
- Pulmonary disease, HIV-positive on HAART
- Disseminated disease
- Non-rifamycin-containing regimen
- Drug-Drug Interactions
- Selected Drug Comments
- OTHER INFORMATION
- Basis for recommendation
- References
- Media
Mycobacterium kansasii- MICROBIOLOGY
- CLINICAL
- SITES OF INFECTION
- TREATMENT
- Pulmonary disease, HIV-negative, or HIV-positive without HAART
- Pulmonary disease, HIV-positive on HAART
- Disseminated disease
- Non-rifamycin-containing regimen
- Drug-Drug Interactions
- Selected Drug Comments
- OTHER INFORMATION
- Basis for recommendation
- References
- Media
- Rifabutin
- Rifabutin
- Kanamycin
- Pyrazinamide
- Pyrazinamide
- Ethambutol
- Ethambutol
- Osteomyelitis, Chronic
- Isoniazid
- Isoniazid
- Streptomycin
- Rifampin
- Rifampin
- Ethionamide
- Amikacin
- Pneumonia, bacterial
- Clarithromycin
- Clarithromycin
- Ciprofloxacin
- Ciprofloxacin
- Mycobacterium spp.
- Trimethoprim + Sulfamethoxazole
- Trimethoprim + Sulfamethoxazole
- Mycobacterium avium-complex (MAC, MAI, non-HIV)
- Mycobacterium scrofulaceum
- Mycobacterium gordonae
- Mycobacterium abscessus
- Mycobacterium fortuitum
- Clofazimine
- Clofazimine